Robbinsville, New Jersey April 14, 2021 – DCAT’s Research & Benchmarking Committee has concluded its latest study, Managing Business Continuity Risks. The newly released study details how Bio/Pharmaceutical companies and suppliers are managing business continuity risks resulting from the COVID-19 pandemic and how lessons learned are affecting their approach to supply-risk management overall.
The findings of this study are now available for download exclusively to all DCAT member company representatives and will also be presented during a complimentary webinar and panel discussion on April 27, 2021 from 10:00 – 11:00 AM ET. Register for the webinar now.
DCAT members may obtain a copy of the report by contacting Erin Sanders at firstname.lastname@example.org or +1-609-208-1888 ext. 7001.
We encourage all DCAT member companies to take advantage of this value-added benefit to evaluate your own company’s best practices for managing supply chain risks in this dynamic global business environment. Please feel free to share his report with colleagues at your company and encourage them to attend the webinar.
Jim Miller, DCAT Content Advisor/Consultant, moderated a panel discussion with DCAT Research and Benchmarking Committee members, which includes representatives from GlaxoSmithKline, Pfizer, and Lonza, among others.
Key takeaways from the report are gathered in this DCAT Value Chain Insights preview article.
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing. With over 400 corporate members, DCAT is headquartered in Robbinsville, New Jersey.
DCAT Sr. Communications & Technology Specialist